Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LIBE. 14 mil os. Trump train. 10 PRs coming.
https://finance.yahoo.com/news/eco-group-libe-announces-joint-133000863.html
ALYI...worth taking a look...
Last month I listened to a Q3 earnings conference call for a company in the automotive sector. The financial numbers were absolutely incredible. What was interesting to me was that during the Q&A about 90% of ALL questions were on the topic of "electrification" (and not the outstanding numbers). The questions were not from the average people on the street or retail shareholders. Rather the questions were from institutional analysts like Goldman, Morgan, Lynch, Suisse, Barclays, Deutsche etc.
So when I look at the testing "partners", the potential in this niche of electrified motorcycles/mopeds, and the high level of interest from the institutional investors...I think this stock has huge potential. Yes it is high risk...but so are 99% of the stocks in the OTC arena.
I think it is worth throwing some cash in this direction to see if ALYI makes some noise.
GLTA
SLAM
What’s with the flashing E*TRADE ads? Dummest advertisement yet. Hurts my eyes flashing like that.
$ADAC On high alert! Closed up 13.00% yesterday. Keep an eye on this one.
$FUSZ 8-K for ORACLE partnership was released yesterday.
#NewNews
$IDVV- California Cannabis company that will rally with legalization. Last trade .12.
$TXHD- Waiting on NEWS regarding their 10 year 25 BILLION dollar government contract they won. Last trade .0004. See you at pennyland imo.
,,,,,,,OLD FLUFF NEWS!
BRSE...MLHC...GLOW...OGEN...EVEP...http://www.profitspi.com/stock/view.aspx?v=stock-chart&uv=110794&p=BRSE#&&vs=636506575555462335
http://www.profitspi.com/stock/view.aspx?v=stock-chart&uv=110794&p=MLHC#&&vs=636506575555462335
http://stockcharts.com/h-sc/ui?s=GLOW
http://stockcharts.com/h-sc/ui?s=OGEN
http://stockcharts.com/h-sc/ui?s=EVEP
$GCEI ON HIGH ALERT>GOLDEN CROSS VERY BULLISH
https://www.investopedia.com/terms/g/goldencross.asp …
http://stockcharts.com/h-sc/ui?s=GCEI&p=D&b=5&g=0&id=p21245170693 …
#MASS #ACCUMULATION @ 6 #YEAR #HIGH
#NEWS #PENDING
#GROSSLY #UNDERVALUED
$GCEI ALERT> MASS ACCUM @ 6 YEAR HIGH+ BUYING GOING THRU THE ROOF!
BTW MONTH OF MAY 60 MILLION SHARES TRADE MOST VOLUME IN GCEI'S HISTORY FOR 1 MONTH
NEWS SOON!
(52 WEEK HIGH .0102)
^^^^^^MFI,A/D^^^^^^
(WEEKLY CHART) (below)
http://stockcharts.com/h-sc/ui?s=GCEI&p=W&yr=5&mn=0&dy=0&id=p25976033638
(DAILY CHART) (below)
http://stockcharts.com/h-sc/ui?s=GCEI&p=D&yr=0&mn=6&dy=0&id=p93071991770
Accumulation/Buying on the chart at these levels should have a significant Upside Move.
http://www.globalcleanenergy.net/
Go GREEN with Global Clean Energy a Enviromentally Friendly Waste Tires to Fuel & Algae to Products Company
glta
$GCEI ON HIGH ALERT>GOLDEN CROSS VERY BULLISH
https://www.investopedia.com/terms/g/goldencross.asp …
http://stockcharts.com/h-sc/ui?s=GCEI&p=D&b=5&g=0&id=p21245170693 …
#MASS #ACCUMULATION @ 6 #YEAR #HIGH
#NEWS #PENDING
#GROSSLY #UNDERVALUED
$GCEI ALERT> MASS ACCUM @ 6 YEAR HIGH+ BUYING GOING THRU THE ROOF!
BTW MONTH OF MAY 60 MILLION SHARES TRADE MOST VOLUME IN GCEI'S HISTORY FOR 1 MONTH
NEWS SOON!
(52 WEEK HIGH .0102)
^^^^^^MFI,A/D^^^^^^
(WEEKLY CHART) (below)
http://stockcharts.com/h-sc/ui?s=GCEI&p=W&yr=5&mn=0&dy=0&id=p25976033638
(DAILY CHART) (below)
http://stockcharts.com/h-sc/ui?s=GCEI&p=D&yr=0&mn=6&dy=0&id=p93071991770
Accumulation/Buying on the chart at these levels should have a significant Upside Move.
http://www.globalcleanenergy.net/
Go GREEN with Global Clean Energy a Enviromentally Friendly Waste Tires to Fuel & Algae to Products Company
glta
$GCEI ON HIGH ALERT>THE SHAREHOLDERS AREN'T GOING DOWN WITHOUT A FIGHT.THEY WILL PREVAIL. $$$$
GO $GCEI
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136982742
What happen to your excc i donot see 100 dollar stock pumper pos
$FUSZ SIGNS DEAL WITH ORACLE!!
Tiny company with small float signs definitive agreement with $ORCL (Oracle America).
$ORCL - market cap of $198 Billion.
$FUSZ - market cap of $13 Million.
$FUSZ also looking at signing similar partnership deals with Salesforce and other leading CRM companies!
Proven CEO Rory Cutaia has sold his previous startup for $200 Million.
$WDRP .0230 MJ/HEMP Stock! Looking for bigger gains!
Accumulation at an all time high and climbing!
https://www.barchart.com/stocks/quotes/WDRP/technical-chart?plot=BAR&volume=0&data=I:240&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=240&indicators=ACCUM;RSI(14,100)&sym=WDRP&grid=1&height=210&studyheight=100
433 million float. No toxic financing. No dilution. Way undervalued!
http://www.otcmarkets.com/stock/WDRP/profile
25 million restricted stock swap with SIPC to gain stake in each other! Worth Near $2 million dollars!
https://www.otcmarkets.com/stock/WDRP/news/Sipp-Industries-Signs-Definitive-Agreement-to-Acquire-Minority-Stake-in-Wanderport-Corporation--Jointly-Introduces-New-Hemp-Beer?id=170786&b=y
Plenty of room to run!
http://www.stockscores.com/quickreport.asp?ticker=Wdrp&x=0&y=0
Websites Below: (New products coming soon!)
http://www.wanderportcorp.com
Sapa CoffeeTM Online Store: http://www.sapacoffee.com
Hemp Oil Supplement: http://www.hempnjuice.com
Facebook:
https://www.facebook.com/WanderportCorporation/
Twitter:
https://twitter.com/wanderportcorp?s=09
Instagram: wanderportcorp
https://www.instagram.com/wanderportcorp/
Hemp Beer in the works!! Partnership with SIPC
Products sold on Amazon!!
https://www.amazon.com/slp/sapa-coffee/3btfbgjevjf23bn
WDRP
$PMCB PharmaCyte Biotech Announces Production of Master Cell Bank PMCB
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today reported that the production of the cells necessary to prepare the Master Cell Bank (MCB) has started. This important work is being carried out by Eurofins, a leading Contract Manufacturing Organization, PharmaCyte selected for this task. Successful development of the MCB is a critical step in PharmaCyte’s preparation for its pancreatic cancer clinical trial.
“The decision to forego a WCB was made because we believe that the MCB will contain more than enough cells for the clinical trial. The goal is to validate PharmaCyte’s unique technology at the earliest opportunity.”
Tweet this
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, stated, “The commencement of the Master Cell Bank (MCB) by Eurofins means that many of the problems discussed during the shareholder call on November 1st have been overcome. When the MCB has been fully populated, the cells will undergo a variety of tests to ensure that they are correct in all respects and then placed in frozen storage for encapsulation and further testing by Austrianova.”
In consultation with principals at Austrianova, PharmaCyte has decided that, once the MCB is fully populated and successfully tested, cells from the MCB will be shipped to Austrianova and used for encapsulation. These encapsulated cells will then be used, along with low-doses of the cancer prodrug ifosfamide, in PharmaCyte’s pancreatic cancer clinical trial.
Waggoner added, “PharmaCyte has decided to proceed with only the MCB for the upcoming clinical trial and, as previously discussed, a Working Cell Bank (WCB) is not required. This will save both a significant amount of time and cost for PharmaCyte in the overall development process of the production of the encapsulated cells.
“The decision to forego a WCB was made because we believe that the MCB will contain more than enough cells for the clinical trial. The goal is to validate PharmaCyte’s unique technology at the earliest opportunity.”
About PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. For pancreatic cancer, these encapsulated cells are implanted in the blood supply to the patient’s tumor as close as possible to the site of the tumor. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide flows through pores in the capsules, the live cells inside act as a “bio-artificial liver” and activate the chemotherapy drug at the site of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no treatment related side effects.
PharmaCyte’s therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes involves encapsulating a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient, they will function as a “bio-artificial pancreas” for purposes of insulin production.
Safe Harbor
This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement because of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements due to the impact of numerous risk factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.
More information about PharmaCyte Biotech can be found at www.PharmaCyte.com. Information may also be obtained by contacting PharmaCyte’s Investor Relations Department.
Contacts
Investor Relations:
PharmaCyte Biotech, Inc.
Dr. Gerald W. Crabtree
Investor Relations Department
917.595.2856
Info@PharmaCyte.com
$SIPC Sipp Industries Signs Definitive Agreement to Acquire Minority Stake in Wanderport Corporation, Jointly Introduces New Hemp B...
Source: InvestorsHub NewsWire
Sipp Industries Signs Definitive Agreement to Acquire Minority Stake in Wanderport Corporation, Jointly Introduces New Hemp Beer
COSTA MESA, CA -- September 26, 2017 -- InvestorsHub NewsWire -- Sipp Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in technology, manufacturing, and distribution of commercial and consumer products is pleased to announce that the Company has signed the definitive agreement to acquire a minority stake of Wanderport Corporation (OTC: WDRP) via a stock swap.
Per the terms of the agreement, the Company will receive twenty five million restricted common shares of Wanderport Corporation in exchange for twenty five million restricted common shares of Sipp Industries.
We are a strong believer of synergistic collaboration and partnerships. We are confident that our collective efforts will result in quality products and services which will benefit the consumers and industry as a whole. We look forward to working with Wanderports team in all future endeavors, commented Syman Vong, CEO of Sipp Industries.
As part of a joint venture, the two companies will collaborate to increase production of Major Hemp Brown Ale (MHBA) and expand its distribution beyond Colorado, starting with California. The Company has identified a local distributor who can place MHBA into establishments in Southern California. Effort is underway to secure and ship the initial order to start the expansion process.
The Company has also been working with a California craft brewery to produce and package MHBA in kegs, cans and bottles for nationwide distribution. As part of the process, the Company has initiated the design of the labels which it expects to submit to TTB sometime next month for approval.
Furthermore, Sipp and Wanderport will jointly produce a new beer flavored with Hemp Coffee which the companies expect to launch next quarter. A test batch of CBD Coffee beers will also be brewed for evaluation and will be made available for distribution if approved.
We are excited to work with Wanderport in executing the expansion plan for our Hemp beer. Our Major Hemp Brown Ale has been receiving rave reviews and is now ready for broader distribution. We look forward to working with the California brewery and Wanderport to make our great tasting beers available everywhere, commented Ted Jorgensen, President of Major Hemp, Sipp Industries wholly owned subsidiary.
Our various flavors of Hemp Sapa CoffeeTM have been selling well both on and off line with great reviews. Coffee flavored craft beers have always been popular so we are very optimistic that our new Hemp Coffee beer will be well received. We could not be more pleased than to work with a partner like Sipp Industries to launch this new product, stated Ty Cha, Wanderport Chief Executive Officer.
Sipp Industries Major Hemp Brown Ale is currently being sold in over thirty locations in Denver, Colorado area.
Wanderports Sapa CoffeeTM product line consists of Hemp coffee in five flavors, including Colombian Supremo, Decaf Colombian Supremo, Italian Roast Espresso, Hazelnut and French Vanilla. Its CBD coffee is available in the Colombian Supremo, Decaf Colombian Supremo and Italian Roast Espresso flavors. The coffees are being sold on Amazon and Sapa CoffeeTM online store.
About Wanderport Corporation
Wanderport Corporation is a premier distributor of food, beverages and consumer products made with hemp. Its premium quality coffee blends are currently being sold in a growing number of grocery stores and small businesses in the Southern California territory. Its products are also sold online at www.sapacoffee.com and www.amazon.com. For more information, please visit http://www.wanderportcorp.com.
About Sipp Industries, Inc.
Sipp Industries is a multifaceted corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. Through its wholly owned subsidiary, Major Hemp, the Company provides high quality and competitively priced hemp based products, bulk hemp, CBD supply, co-packing and private labeling services.
Website: http://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
Twitter: @SippIndustries
***MUST SEE FOR OTC TRADERS/INVESTORS***
https://madmimi.com/s/7fa05b?o=tm
FUTURE BILLION DOLLAR COMPANY...OTTV.0017
GLOBAL ADVERTISEMENT CAMPAIGN HAS JUST BEGUN.
4.8 OUT OF 5 STAR RATING FROM CURRENT CUSTOMERS.
FANTASTIC PRODUCT AND EVEN BETTER CUSTOMER SERVICE.
(I KNOW, I SUBSCRIBE)
R&D STAGE IS OVER...........IT's REVENUE TIME
GET 10 TIMES THE VIEWING FOR 1/4 THE COST OF CABLE.
REVENUE POTENTIAL... $35. TIMES 12 MONTHS TIMES GLOBAL CUSTOMERS
EARLY BIRDS GET THE WORMS...
HTTP://vivalivetv.com
$VATE Elev8 HEMP Tea's Now Sold On Amazon!
https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Elev8+Hemp
#VATE
Re: SRMX .002 - you ladies and gentleman may wish to read this, as we have quite a few catalysts this week and next that can propel this one off the bottom
Also for those realizing that SRMX is on the cusp (literally any day now)of obtaining a new company name and ticker symbol, well that is slated to go into effect this Friday.
The new website will be
http://www.skiqnow.com
It's password protected at the moment because they are getting it ready for launch.
But read below to see all the catalysts that are directly in our path.
$TWMJF $ACBFF $APHQF $IMLFF $CBDS $NUGS $CRWG $VAPI $XSNX $HPMM $IGPK $CBCA
Charts 1/3/18
TA Video
Trump make sure Alonzo Smith gets the death penalty. He killed a Deputy Sheriff friend of mine Larry Falce. Please Sir keep making America great again fry this Son of a Bitch!!https://t.co/wPkSVzV6Ib https://t.co/fAUZtqTYSB
— BoilerRoom (@BoilerRoom7) January 4, 2018
Oncolix OTC: ONCX is a pharmaceutical company that is in phase one, of FDA clinical human trials for Cancer treatment.
Early funding for this research came from the Susan G. Komen Foundation and the U.S. Government.
Oncolix as a private company had completed several rounds of private offerings that are only available to accredited investors, family trusts, endowments and institutional investors.
Accredited investors to date include the Greenville Hospital System, the Texas Emerging Technology Fund and the Ernest Mario Family Trust among others.
Ernest Mario served as Chief Executive Officer of Glaxo Holdings, plc, based out of London, England, known today as GlaxoSmithKline NYSE:GSK.
Ernest Mario was also the Chairman and CEO of Alza Corporation, based in Palo Alto, CA, from 1993 until the company was purchased by Johnson & Johnson, Inc, NYSE: JNJ in 2001.
Oncolix CEO Michael Redman discusses Oncolix, the progress of its Cancer treatment drug Prolanta, as well as Oncolix becoming a public company.
He also states his ambition to eventually have Oncolix listed on the NASDAQ.
QuoteMedia Announces Debt Exchange and Executive Compensation Agreements
https://globenewswire.com/news-release/2018/01/03/1277315/0/en/QuoteMedia-Announces-Debt-Exchange-and-Executive-Compensation-Agreements.html
PHOENIX, Jan. 02, 2018 (GLOBE NEWSWIRE) -- QuoteMedia, Inc. (OTCQB:QMCI),a leading provider of market data, cloud-based financial web content solutions and stock market applications, announced that on December 28, 2017, the Company executed agreements that result in a major strengthening of both the Company’s capital structure, and its operating cost structure.
QuoteMedia entered into a Debt Exchange Agreement with Bravenet Web Services, Inc. and Harrison Avenue Holdings Ltd., pursuant to which Bravenet and Harrison agreed to exchange an aggregate of $3,192,116 of indebtedness of the Company held by Bravenet and Harrison for (a) 127,685 shares of a newly created class of preferred stock designated as Series A Redeemable Convertible Preferred Stock, par value $0.001 per share, of the Company, and (b) warrants to purchase up to 4,000,000 shares of common stock, par value $0.001 per share, of the Company at an exercise price equal to $0.10 per share.
David M. Shworan, the President and Chief Executive Officer of QuoteMedia, Ltd., a wholly owned subsidiary of the Company, a member of the Company’s board of directors, is a control person of Bravenet and Harrison.
On December 28, 2017, the Company also entered into a Debt Forgiveness Agreement with Bravenet and Harrison, pursuant to which Bravenet and Harrison agreed to forgive an aggregate of $1,157,752 of indebtedness of the Company held by Bravenet and Harrison in exchange for $1.00.
On December 28, 2017, the Company also entered into a Compensation Agreement with David M. Shworan, pursuant to which the Company will issue to Shworan (a) a warrant to purchase up to 1,250 shares of Series A Preferred Stock at an exercise price equal to $1.00 per share, (b) a warrant to purchase up to 382,243 shares of Series A Preferred Stock at an exercise price equal to $1.00 per share, and (c) a warrant to purchase up to 4,000,000 shares of Common Stock at an exercise price equal to $0.10 per share (which warrant has specific performance vesting thresholds).
In addition, Mr. Shworan’s compensation for each of 2018 and 2019 will be warrants to purchase up to 15,000 shares of Series A Preferred Stock at an exercise price equal to $1.00 per share.
Beginning in 2020, Mr. Shworan will receive regular salary compensation.
As a result of these agreements and transactions, an aggregate total of $12,374,100 of related party debt has been eliminated from the Company’s balance sheet; and, concurrently, the capital base of the Company has been strengthened by a similar amount.
Further, all ongoing interest expense relating to the exchanged or forgiven debt has also been eliminated and will no longer be a factor in calculating the net income of the Company.
Mr. Robert Thompson, QuoteMedia’s Chairman noted: “This is a major restructuring event that unburdens the Company’s underlying strengths. The elimination of all related party debt strengthens both QuoteMedia’s balance sheet and cost structure.
The termination of the annual interest expense of approximately $1.3 million related to this debt will significantly improve QuoteMedia’s operating results in 2018 and beyond.
For more detailed information, please refer to our Form 8-K dated January 2, 2018.
About QuoteMedia
QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies. The Company licenses interactive stock research tools such as streaming real-time quotes, market research, news, charting, option chains, filings, corporate financials, insider reports, market indices, portfolio management systems, and data feeds. QuoteMedia provides data and services for companies such as the NASDAQ Stock Exchange, TMX Group (TSX Stock Exchange), Dow Jones & Company, FIS, U.S. Bank, Broadridge Financial Systems, Ridge Clearing, JP Morgan, CIBC, JitneyTrade, Hilltop Securities, HD Vest, Intrinsic Research Systems, ING Investment Management, Stockhouse, Zacks Investment Research, General Electric, Dow Chemical, Boeing, Bombardier, Business Wire, PR Newswire, Marketwired, FolioFN, Regal Securities, ChoiceTrade, Cetera Financial Group, Dynamic Trend, Inc., Qtrade Financial, CNW Group, Industrial Alliance, TradeKing, Suncor, Virtual Brokers, Equities.com, Leede Jones Gable, Vision Financial Markets, Firstrade Securities, Divy Inc., Motif Investing, First Financial, Cirano, Equisolve, Stock-Trak, Mergent, SNN Incorporated and others. Quotestream®, QModTM and Quotestream ConnectTM are trademarks of QuoteMedia. For more information, please visit: www.quotemedia.com.
Statements about QuoteMedia's future expectations, including future revenue, earnings, and transactions, as well as all other statements in the press release other than historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. QuoteMedia intends that such forward-looking statements be subject to the safe harbors created thereby. These statements involve risks and uncertainties that are identified from time to time in the Company's SEC reports and filings, and are subject to change at any time. QuoteMedia's actual results and other corporate developments could differ materially from that which has been anticipated in such statements.
QuoteMedia
Dave Shworan, (877) 311-9911 ext. 101
contactus@quotemedia.com
IMO and FWIW.
Global Water Technologies releases annual shareholder letter
JANUARY 1, 2018
http://www.gwtr.com/news_01-01-2018.php
"Dear Shareholders of Global Water Technologies,
Our annual shareholder letter has considerable progress to report. The company continues to move forward on all three areas of focus: non-chemical water treatment, smart water solutions and trenchless technologies.
Global Water Technologies has been working to integrate and commercialize solutions in these three areas. Its legacy business of non-chemical water treatment; use of “smart water” technologies that leverage sensors and software to improve efficiency; and trenchless technologies that provide cost-effective rehabilitation for water infrastructure.
Several significant steps that we had planned to announce in the fourth quarter of 2017 have been delayed and work toward those efforts will continue into the new year. While it can be exceedingly frustrating to see the impact of such delays on the company’s revenues and share price, the foundation is now in place to rapidly change both important metrics.
In a recent discussion with one of our industry’s top technology executives, he observed the water sector is challenging due to its propensity to routinely delay projects, often by months and years. That makes it difficult to implement and rapidly scale new innovations that can improve efficiency and customer service for water utilities.
As a small tech company, we have experienced these challenges in several areas. For example, we were one of the first to locate in the 16 Tech innovation district of Indianapolis, which was targeted in late 2015 for $75 million of (mostly water) infrastructure development by the city. In early 2016, we hosted an international water infrastructure demonstration in the area that was well attended by local, state and national leaders. However, unexpected external events have delayed initial work on the project for the past two years. A deal closed for business in China with the demonstrated technology was also sidelined in 2017.
Likewise, the pace of policy adoption that is key to water infrastructure funding has also been slow. Our company was an initial member of the US EPA water cluster initiative in 2011. We were early supporters of the federal Water Infrastructure Financing and Innovation Act (WIFIA) that passed in 2013 with bipartisan support. And we testified before the Indiana Utility Regulatory Commission that year on the need for water innovation and presented our Smart Water for Indiana plan to the governor’s office, which was followed by two statewide studies on water supply and utility needs.
In late 2016, we coordinated a smart cities proposal for Indianapolis that focused on smart water, energy and transportation. It was selected as a finalist from among more than 120 competing metropolitan areas and announced as one of five winners for 2017. That effort resulted in positioning our company at the intersection of smart water and smart cities, an effort we outlined over the past year at events in Boston, Washington DC, Chicago, Austin, San Diego and San Francisco. Strategic partnerships were established at these events, which included those hosted by Smart Cities Council, Smart Cities Connect, SWAN North America, Sensus/Xylem, Water 2.0 and US EPA.
Now all those efforts are positioned to generate positive results in 2018. The new WIFIA program that is being administered by US EPA has selected Indiana as its first statewide recipient and that should lead to $436 million of federal financing for water infrastructure. We believe this will create a unique opportunity to showcase water innovation and best practices in dozens of communities across the state, just as the national discussion turns to infrastructure issues in the coming year. We also expect Indiana leadership on the topic of smart cities with potential federal legislation moving in 2018.
To take advantage of these smart water opportunities, we have established a strong network of strategic partners and potential investors. As a small public company that is perfectly positioned and focused on this space, we believe there is an opportunity to secure the working capital that has been lacking and is needed to move the company beyond the bootstrapping operations of the past several years.
While we believe that smart water infrastructure presents the greatest opportunity for 2018, the company has also continued its work in both trenchless technologies and non-chemical water treatment. Both of those areas have generated revenues for the company (primarily from Asia) in the past year and are expected to continue growth in 2018. The company has also refiled a provisional patent application for an invention using non-chemical water treatment.
Last year we selected the Global Water Solutions Fund (HTO-UN.TO) as a benchmark for our progress and noted its 2016 share price increasing from $6.82 to $7.73 (+13.3%). In 2017, that fund’s closing price was $10.21 (+32.1%) and Global Water Technologies stock failed to keep pace.
In 2016, 1,074,636 shares of GWTR stock traded at prices between $0.01 and $0.04 and the closing price was $0.03. In 2017, 713,375 shares traded at prices between $0.01 and $0.045 and the closing price was $0.01. While OTC stocks are often volatile and require caution in analysis (see our Investors page), the company intends to focus on securing both higher volumes and share prices in 2018.
The number of common shares at December 31, 2017 is 21,882,146 and the number of free-trading shares remains at 5,895,503. The company has issued warrants for the purchase of 2 million shares at $0.015 and has reserved 1.75 million shares for convertible promissory notes totaling $81,500. Continued avoidance of both toxic financing and related stock promotion allows for the issuance of additional shares in a manner that creates value for new and existing shareholders.
Given the considerable effort and investment to date, the unique water infrastructure opportunity taking shape and the low $0.01 closing price for 2017, we expect the coming year to present significant gains for GWTR shareholders.
Thank you to all our shareholders, team members, vendors and customers who have supported Global Water Technologies over the past year. We look forward to an exciting and productive 2018!
Sincerely,
Erik Hromadka
Chairman and CEO"
IMO and FWIW.
All good. I know you mean no harm. It will bounce HIGH soon! Be ready!
$RENN $TRX.X $REXX $SDRL $ENRJ $JONE $SAEX $EVEP $GST $APHB $HGSH $CHCI $ATTBF
Charts 1/3/18
TA Video
$QUES Huge Revenue, low float gem. Revenues just through Quarter 3 are $41 million!
Tremendous upside here, near 52 week low bounce. Going back to .50.
Authorized Shares - 100,000,000
Outstanding Shares - 36,809,777
Restricted - 18,561,144
Float - 18,248,633.
$QUES has reached a three-year supply agreement with a US-based multibillion dollar Fortune 500 corporation for the supply of mobile equipment enabling more efficient supply chain and inventory management. The first stage of the project is expected to be completed within 12 months of the start date with a total expected value of over $4M.
$CBGH new CEO $$$ https://pbs.twimg.com/media/DSpH0tjVAAAHAto?format=jpg&name=large
Dave, you may want to read the Second Circuit's recent opinion first. Digest it. And then let's talk about it.
Good Night
$GRCU California ready to go green with legalization of marijuana in 2018 https://www.cbsnews.com/news/california-recreational-marijuana-legalization-in-2018/
What "activity" ? people buying? Thats illegal? Buying stop sign stocks lol arrest warrants for all!
**********PDXP _ MJ BOMB: _ https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137392441
SIGO man. I could use some beginners luck :) but look into SIGO. A pot play that can go ballistic on any news or momo small float hot industry. California just legalized. Even has a quarterly dividend!
SIGO california MJ play, new license 2 days ago, breakout on chart, low float, trading 1/7th of peers within its industry, more catalysts,Quarterly dividends
which stock has more to offer?
what's the question?
Long term $6+ conservative
$FUSZ .1295 Signs Definitive Agreement With $ORCL:NYSE (Oracle Corp.).....This is Huge!
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12456078
first trade in pennystocks or in general?. Paper trade first, then throw in real $$$ gl.
Crazy real life example, that I was part of, that just goes to show how "too obvious" traps can work - see how I got suckered into the trap HERE
can anyone help me our with my first trade tomorrow,my first trade,a good pointer anyways.the names casper.really new.thanks
$PSNX huge volume today. Watching for move out of trips imo
OCSY $$$$$$$$$$$ alert boom tomorrow .0004/5
Followers
|
9997
|
Posters
|
|
Posts (Today)
|
162
|
Posts (Total)
|
4970500
|
Created
|
01/10/04
|
Type
|
Free
|
Moderator i_like_bb_stock | |||
Assistants koolmc MOMO vantillian Rainer StockRocket |
Goal: TO PROVIDE A FORUM FOR BOTH EXPERIENCED AND NOVICE TRADERS TO SHARE THEIR OPINIONS ON STOCKS TRADED ON THE BULLETIN BOARD OR PINK SHEET MARKETS, AS WELL AS THE BIG BOARDS. FUNDAMENTALS, NEWS, RUMORS ARE WELCOME, BUT FOR THE MOST PART, THIS BOARD WILL BE TO SHARE TECHNICAL ANALYSIS. TIMING IS EVERYTHING WHEN BUYING OR SELLING A STOCK, AND TECHNICAL ANALYSIS CAN OFTEN DETERMINE THE APPROPRIATE ACTION TO TAKE. ALL TECHNICAL INDICATORS ARE WELCOME. FOR NOVICE TRADERS, QUESTIONS ARE WELCOMED, AND SOMEONE WILL TRY AND HELP YOU WITH THE ANSWER. I WAS ONCE A NOVICE TRADER, AND KNOW THAT GUIDANCE WOULD HAVE HELPED ME SEVERAL YEARS AGO, SO I WOULD LIKE TO HELP YOU AS MUCH AS POSSIBLE. -- i_like_bb_stock |
Rules:1) Spam of any kind will not be tolerated2) There will be times when posters are not in agreement, that is healthy, but please no personal attacks. 3) No specific price preference for the board but these are mostly OTC stocks. 4) Volume is the blood in a stock's veins, so I typically prefer stocks with historical volume, otherwise there is little liquidity for selling the stock if need be. 5) Posting charts and annotations if you have a service that provides it are highly welcome since this provides support for your buy/sell/hold signal. 6) As always, do your due diligence, and remember that there is high risk in these types of stocks. Never trade with money that you cannot afford to loose. 7) If the post is Off Topic, please post with OT prefacing the post. |
Some relevent info:1) For SEC filings I use www.otcmarkets.com.2) For daily charts I use www.stockcharts.com. There is a free service which is time delayed, and then different levels of paid service. 3) To post a chart from stockcharts.com, right click on the chart, click "Copy Image URL". Within the post, right click and click Paste. Remove "http://" then place the chart URL between these tags [*chart]URL[*/chart] (remove the asterisks) 4) For level II, there are various services, IHUB has its own services, individual brokers as well, I use TDAmeritrade, which offers free level II if you have an account. 5) I use equityfeed.com which is critical for any otc trader. It has level II as well, real time news, scanning, and a plethora of things that are needed as a trader. There are various price points based on your needs. 6) For a great listing of stock terms or investor information, use www.investopedia.com or www.investorwords.com. 7) For more info on chart formations, see http://www.chartpatterns.com and http://thepatternsite.com. 8) To find splits, symbol changes etc., use http://otce.finra.org/DailyList 9) Remember also to sell into strength and buy into weakness. When possible, try not to sell at the bid. When a stock is strong, you can usually at least get filled somewhere between the bid/ask, selling at the bid will often hurt the stock, since the market makers make take the bid down further afterwards. 10) For info on stockcharts.com, see the Stockcharts board on the Hub: http://www.investorshub.com/boards/board.asp?board_id=1277 |
Posts Today
|
162
|
Posts (Total)
|
4970500
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |